CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

Research agreement to advance new imaging technology

The University of Rochester Medical Center (URMC) and T.I.E.S., LLC, a Rochester-based start-up company, have entered into a research partnership to evaluate a new technology that could ultimately represent a major advance in medical imaging.

29 Mar 2007

Surgical improvements for Crohn's disease sufferers

Decades of painstaking research has yielded the most in-depth look ever at the management of bowel stricture recurrence in patients who undergo surgery for Crohn's disease. The findings should provide much-needed guidance to surgeons and gastroenterologists battling this tough-to-manage intestinal disorder.

20 Feb 2007

Sharper MRI's

Magnetic resonance imaging, or MRI, has revolutionized health care, providing doctors with a highly accurate, non-invasive tool for diagnosing cancer, injuries and other maladies within the human body. Now, a Florida State University researcher has collaborated in a research project that could lead to ways of producing even sharper medical images.

13 Feb 2007

MedImmune statement on MedImmune vs. Genentech Supreme Court decision

MedImmune issued the following statement regarding today's U.S. Supreme Court decision in MedImmune, Inc. vs. Genentech, Inc. et al.

9 Jan 2007

Bush Administration says it opposes Democrats' plan to allow Government to negotiate Medicare drug prices

The Bush administration will oppose any attempts by congressional Democrats to pass legislation that would authorize the government to negotiate with pharmaceutical companies under the Medicare prescription drug benefit, according to HHS Secretary Mike Leavitt, the New York Times reports.

13 Nov 2006

Myths surrounding HIV/AIDS epidemic in Asia

"Five Myths About the HIV Epidemic in Asia," PLoS Medicine: Peter Godwin, senior adviser at the National Centre for HIV/AIDS, Dermatology and STDs in Phnom Penh, Cambodia, and colleagues in the article discuss five "commonly held" myths regarding HIV/AIDS in Asian countries.

8 Oct 2006

Quality indicators for gastrointestinal endoscopic procedures

Defining measurements and identifying quality standards in the delivery of colonoscopic care is a major priority for the nation's leading gastrointestinal endoscopic healthcare association.

13 Sep 2006

FDA approves Plavix for STEMI heart attacks

The Food and Drug Administration (FDA) today approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty).

17 Aug 2006

FDA cracks down on fake drugs

A draft policy from the FDA's counterfeit drug task force, concerns drugs marketed in the United States that do not have required FDA approval and emphasizes the regulatory actions and the use of new technologies for safeguarding the integrity of the U.S. drug supply.

12 Jun 2006

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

The findings come three years after a related WHI study found that a different type of hormone therapy - which combined estrogen and progestin - did result in a higher risk of breast cancer among postmenopausal women.

13 Apr 2006

Researchers test system at Cleveland-area hospitals that address family decision-making

A growing population of chronically critically ill (CCI) patients use approximately half of all hospital intensive care unit (ICU) resources at a cost of an estimated $50 billion annually. In turn, health care providers pass those costs onto the consumer.

13 Mar 2006

British woman loses Herceptin court battle

A mother of three in the UK suffering from the early-stage of an aggressive form of breast cancer, has lost her high court battle to force her health authority to pay for the potentially life-saving drug Herceptin.

16 Feb 2006

Heart risk warning wanted on ADHD drugs

A U.S. advisory panel has recommended that drugs used by millions to treat attention deficit hyperactivity disorder (ADHD), should carry a warning of the risk of heart problems.

12 Feb 2006

Effects of mobile phones on attention

Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.

7 Dec 2005

Another bird flu death as $1 billion plan revealed to fight virus

The announcement by Health experts of a $1 billion plan to halt the spread of bird flu came at the same time as Indonesia said initial tests showed the virus had killed a 16-year-old girl.

9 Nov 2005

CSIRO's RNAi 'gene silencing' patents strengthened

The patent landscape for RNAi 'gene silencing' - including CSIRO's hairpin RNAi technology - has been significantly clarified following the resolution of several opposition and re-examination cases in Australia.

26 Oct 2005

Importance of the drug Fuzeon (enfuvirtide) in the management of HIV

New potent combinations make suppression of virus to undetectable levels more achievable for treatment-experienced HIV patients.

20 Oct 2005

Hospitals alter billing and collection practices for uninsured patients

Many hospitals have adopted more generous charity-care guidelines for uninsured patients after a barrage of publicity about aggressive hospital billing and collection practices and a spate of lawsuits alleging hospitals overcharged uninsured patients, according to a study released today by the Center for Studying Health System Change (HSC).

12 Oct 2005

Biothera's beta glucan patents upheld

Cypress Systems Inc. has agreed to stop selling yeast beta glucan and has acknowledged the validity of Biothera's patents as part of the settlement of a lawsuit filed in federal district court last March.

10 Oct 2005

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduced the risk of cardiovascular death, heart attack or stroke within 30 days following the procedure, according to an article in the September 14 issue of JAMA: The Journal of the American Medical Association.

5 Sep 2005